• Expert opinion

    Expert Professors Elisabeth Bendstrup and Kristin Highland answer our questions about interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF).

  • Latest treatments for IPF

    Learn about anti-fibrotic treatments available for patients with idiopathic pulmonary fibrosis (IPF).

  • Burden of IPF

    Idiopathic pulmonary fibrosis (IPF) greatly affects patients’ quality of life due to severe symptoms, disease course uncertainty and poor prognosis.

  • Diagnosis of IPF

    Find out how to diagnose idiopathic pulmonary fibrosis (IPF).

  • International guidelines for IPF

    Learn about international guideline recommendations for the treatment of idiopathic pulmonary fibrosis (IPF).


Idiopathic Pulmonary Fibrosis (IPF) Learning Zone

Welcome to the IPF Learning Zone. IPF is a chronic and progressive fibrotic interstitial lung disease that occurs mostly in older adults, is limited to the lungs and often displays a characteristic imaging and histological appearance. Find out more about IPF in the disease awareness section, such as epidemiology, pathophysiology, symptoms and diagnosis. Learn about the latest interventions available for patients in the treatment section, including treatment pathways and guideline recommendations.

The epgonline.org team was at the ERS Congress 2019 filming Professors Elisabeth Bendstrup and Kristin Highland. A question and answer session is avaialble here.
We discussed the latest research and the treatment landscape in IPF and other types of interstitial lung disease with them, in order to develop two EACCME® accredited E-learning modules. Make sure you are registered with epgonline.org to be notified when they are available.  

Disease awareness

Disease awareness

Explore the epidemiology, pathophysiology, symptoms and diagnosis of IPF.



Learn about the treatment pathways that are available for patients with idiopathic pulmonary fibrosis (IPF) and discover what therapies are recommended by the latest international guidelines.

Expert Opinion

Expert Opinion

Find out from Professor Elisabeth Bendstrup why she finds IPF such a fascinating disease as a physician and from Professor Kristin Highland discussing patient care with ILD.


Login/ Register Maximise Minimise